Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 4 of 4 entries
View as:

PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.

Phase: N/A Priority: Normal
NCT ID: NCT06486220 Org: User:
Start: 07/01/24 End: 07/01/26 Due: 07/01/27

Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Phase: N/A Priority: Normal
NCT ID: NCT02735317 Org: User:
Start: 04/30/16 End: 06/30/17 Due: 06/30/18

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

Phase: N/A Priority: Normal
NCT ID: NCT02590133 Org: User:
Start: 07/31/15 End: 12/31/20 Due: 12/31/21

Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Phase: N/A Priority: Normal
NCT ID: NCT02729324 Org: User:
Start: 04/30/16 End: 06/30/17 Due: 06/30/18